Timeline: International Phase 3 Clinical Trial of Verdiperstat in Multiple System Atrophy “Top line results from the study are expected to be available in 3rd Quarter of 2021 and will help to characterize the potential benefits and risks of Verdiperstat in MSA....
Defeat MSA Alliance Board of Directors and affiliated charities in the MSA United Consortium are pleased to announce the second Annual All-Community MSA Conference to be held October 1-3, 2021. This year’s conference will include several exciting educational...
Recent Comments